Skip to main content
Erschienen in: Supportive Care in Cancer 1/2016

01.01.2016 | Original Article

Late effects of cancer and cancer treatment—the perspective of the patient

verfasst von: Charlene Treanor, Michael Donnelly

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Understanding the experience of late effects from the perspective of cancer survivors is essential to inform patient-centred care. This study investigated the nature and onset of late effects experienced by survivors and the manner in which late effects have affected their lives.

Methods

Sixteen purposively selected cancer survivors participated in a qualitative interview study. The data were analysed inductively using a narrative schema in order to derive the main themes that characterised patients’ accounts of late effects.

Results

Individual survivors tended to experience more than one late effect spanning a range of physical and psychological effects. Late effects impacted on relationships, working life, finances and the ability to undertake daily activities. Survivors reported experiencing psychological late effects from around the end of treatment whereas the onset of physical effects occurred later during the post-treatment period. Late effects were managed using formal health services, informal social support and use of ‘wellbeing strategies’. Survivors engaged in a process of searching for reasons for experiencing late effects and struggled to make sense of their situation. In particular, a process of ‘peer-patient comparison’ was used by survivors to help them make sense of, or cope with, their late effects. There appeared to be an association between personal disposition and adaptation and adjustment to the impact of late effects.

Conclusions

Cancer survivors identified potential components for supported self-management or intervention programmes, as well as important considerations in terms of peer comparisons, personal disposition and making sense of experienced late effects.
Literatur
1.
Zurück zum Zitat Coleman MP, Forman D, Bryant H et al (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377:127–138. doi:10.1016/S0140-6736(10)62231-3 Coleman MP, Forman D, Bryant H et al (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377:127–138. doi:10.​1016/​S0140-6736(10)62231-3
2.
Zurück zum Zitat Department of Health, Macmillan Cancer Support and NHS Improvement (2013) Living with and beyond cancer: taking action to improve outcomes. Williams Lea, London Department of Health, Macmillan Cancer Support and NHS Improvement (2013) Living with and beyond cancer: taking action to improve outcomes. Williams Lea, London
4.
Zurück zum Zitat Treanor C, Santin O, Mills M, Donnelly M (2013) Cancer survivors with self-reported late effects: their health status, care needs and service utilisation. Psychooncology 22:2428–2435. doi:10.1002/pon.3304 CrossRefPubMed Treanor C, Santin O, Mills M, Donnelly M (2013) Cancer survivors with self-reported late effects: their health status, care needs and service utilisation. Psychooncology 22:2428–2435. doi:10.​1002/​pon.​3304 CrossRefPubMed
5.
Zurück zum Zitat Selamat MH, Loh SY, Mackenzie L, Vardy J (2014) Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications. PLoS One 9:e108002. doi: 10.1371/journal.pone.0108002 Selamat MH, Loh SY, Mackenzie L, Vardy J (2014) Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications. PLoS One 9:e108002. doi: 10.​1371/​journal.​pone.​0108002
6.
7.
Zurück zum Zitat Macmillan Cancer Support (2013) Cured—but at what cost? Long-term consequences of cancer and its treatment. Macmillan Cancer Support, London Macmillan Cancer Support (2013) Cured—but at what cost? Long-term consequences of cancer and its treatment. Macmillan Cancer Support, London
10.
Zurück zum Zitat Tighe M, Molassiotis A, Morris J, Richardson J (2011) Coping, meaning and symptom experience: a narrative approach to the overwhelming impacts of breast cancer in the first year following diagnosis. Eur J Oncol Nurs 15:226–232. doi:10.1016/j.ejon.2011.03.004 CrossRefPubMed Tighe M, Molassiotis A, Morris J, Richardson J (2011) Coping, meaning and symptom experience: a narrative approach to the overwhelming impacts of breast cancer in the first year following diagnosis. Eur J Oncol Nurs 15:226–232. doi:10.​1016/​j.​ejon.​2011.​03.​004 CrossRefPubMed
13.
Zurück zum Zitat Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19:349–357. doi:10.1093/intqhc/mzm042 CrossRefPubMed Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19:349–357. doi:10.​1093/​intqhc/​mzm042 CrossRefPubMed
14.
Zurück zum Zitat Sagen A, Kaaresen R, Sandvik L, Thune I, Risberg MA (2014) Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures. Arch Phys Med Rehabil 95:875–881. doi:10.1016/j.apmr.2013.12.015 CrossRefPubMed Sagen A, Kaaresen R, Sandvik L, Thune I, Risberg MA (2014) Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures. Arch Phys Med Rehabil 95:875–881. doi:10.​1016/​j.​apmr.​2013.​12.​015 CrossRefPubMed
17.
20.
Zurück zum Zitat Gill KM, Mishel M, Belyea M, et al (2004) Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors. Oncol Nurs Forum 31:633–639. doi:10.1188/04.ONF.633-639 Gill KM, Mishel M, Belyea M, et al (2004) Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors. Oncol Nurs Forum 31:633–639. doi:10.​1188/​04.​ONF.​633-639
22.
23.
Zurück zum Zitat Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It’s not over when it’s over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181. doi:10.2190/PM.40.2.c CrossRefPubMed Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It’s not over when it’s over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181. doi:10.​2190/​PM.​40.​2.​c CrossRefPubMed
24.
Zurück zum Zitat Connerty TJ, Knott V (2013) Promoting positive change in the face of adversity: experiences of cancer and post-traumatic growth. Eur J Cancer Care 22:334–344. doi:10.1111/ecc.12036 CrossRef Connerty TJ, Knott V (2013) Promoting positive change in the face of adversity: experiences of cancer and post-traumatic growth. Eur J Cancer Care 22:334–344. doi:10.​1111/​ecc.​12036 CrossRef
25.
Zurück zum Zitat Macmillan Cancer Support (2009) It’s no life: living with the long term effects of cancer. Macmillan Cancer Support, London Macmillan Cancer Support (2009) It’s no life: living with the long term effects of cancer. Macmillan Cancer Support, London
26.
Zurück zum Zitat Shaw AK, Pogany L, Speechley KN, Maunsell E, Barrera M, Mery LS (2006) Use of health care services by survivors of childhood and adolescent cancer in Canada. Cancer 106:1829–1837. doi:10.1002/cncr.21798 CrossRefPubMed Shaw AK, Pogany L, Speechley KN, Maunsell E, Barrera M, Mery LS (2006) Use of health care services by survivors of childhood and adolescent cancer in Canada. Cancer 106:1829–1837. doi:10.​1002/​cncr.​21798 CrossRefPubMed
27.
Zurück zum Zitat Harris SR, Hugi MR, Olivotto IA, Levine M (2001) Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema CMAJ 164:191–199PubMed Harris SR, Hugi MR, Olivotto IA, Levine M (2001) Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema CMAJ 164:191–199PubMed
29.
Zurück zum Zitat Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M, Byers T (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:243–274. doi:10.3322/caac.21142 CrossRefPubMed Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M, Byers T (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:243–274. doi:10.​3322/​caac.​21142 CrossRefPubMed
30.
Zurück zum Zitat Mishra SI, Scherer RW, Geigle PM, Topaloglu O, Gotay CC, Snyder C (2012) Exercise interventions on health-related quality of life for cancer survivors (review). Cochrane Database Syst Rev 8. doi: 10.1002/14651858.CD007566.pub2. Mishra SI, Scherer RW, Geigle PM, Topaloglu O, Gotay CC, Snyder C (2012) Exercise interventions on health-related quality of life for cancer survivors (review). Cochrane Database Syst Rev 8. doi: 10.​1002/​14651858.​CD007566.​pub2.
31.
Zurück zum Zitat Shneerson C, Taskila T, Holder R (2014) Patterns of self-management practices undertaken by cancer survivors: variations in demographic factors. Eur J Cancer Care doi:. doi:10.1111/ecc.12252 Shneerson C, Taskila T, Holder R (2014) Patterns of self-management practices undertaken by cancer survivors: variations in demographic factors. Eur J Cancer Care doi:. doi:10.​1111/​ecc.​12252
34.
Zurück zum Zitat American Psychiatric Association (2013) Diagnostic statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington American Psychiatric Association (2013) Diagnostic statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington
39.
Zurück zum Zitat Brakel TM, Dijkstra A, Buunk AP, Siero FW (2012) Impact of social comparison on cancer survivors’ quality of life: an experimental field study. Health Psychol 31:660–670. doi:10.1037/a0026572 CrossRefPubMed Brakel TM, Dijkstra A, Buunk AP, Siero FW (2012) Impact of social comparison on cancer survivors’ quality of life: an experimental field study. Health Psychol 31:660–670. doi:10.​1037/​a0026572 CrossRefPubMed
43.
Zurück zum Zitat Feros DL, Lane L, Ciarrochi J, Blackledge JT (2013) Acceptance and commitment therapy (ACT) for improving the lives of cancer patients: a preliminary study. Psychooncol 22:459–464. doi:10.1002/pon.2083 Feros DL, Lane L, Ciarrochi J, Blackledge JT (2013) Acceptance and commitment therapy (ACT) for improving the lives of cancer patients: a preliminary study. Psychooncol 22:459–464. doi:10.​1002/​pon.​2083
44.
Zurück zum Zitat Fiszer C, Dolbeault S, Sultan S, Brédart A (2014) Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: a systematic review. Psychooncol 23:361–374. doi:10.1002/pon.3432 CrossRef Fiszer C, Dolbeault S, Sultan S, Brédart A (2014) Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: a systematic review. Psychooncol 23:361–374. doi:10.​1002/​pon.​3432 CrossRef
45.
Zurück zum Zitat Paschali AA, Hadjulis M, Papadimitriou A, Karademas EC (2015) Patient and physician reports of the information provided about illness and treatment: what matters for patients’ adaptation to cancer during treatment? Psychooncol doi:. doi:10.1002/pon.3741 Paschali AA, Hadjulis M, Papadimitriou A, Karademas EC (2015) Patient and physician reports of the information provided about illness and treatment: what matters for patients’ adaptation to cancer during treatment? Psychooncol doi:. doi:10.​1002/​pon.​3741
Metadaten
Titel
Late effects of cancer and cancer treatment—the perspective of the patient
verfasst von
Charlene Treanor
Michael Donnelly
Publikationsdatum
01.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2796-4

Weitere Artikel der Ausgabe 1/2016

Supportive Care in Cancer 1/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.